Aptamers Market

Aptamers are high affinity molecules that are derived from RNA or DNA. These are normally generated using a synthetic process called Systematic evolution of ligands by exponential enrichment (SELEX).

Aptamers receive their name from the Latin word aptus meaning fit . This means they bind to the target molecules with high specificity and high affinity.

Aptamers are short nucleic acids that interact with a variety of targets with high affinity and specificity. They have been shown to inhibit biological functions of cognate target proteins, and they are identifiable by an in vitro selection process, also termed SELEX (Systematic Evolution of Ligands by EXponential enrichment). Being nucleic acids, aptamers can be synthesized chemically or enzymatically.

Aptamers Market contains market size and forecasts of Aptamers in Global, including the following market information:

Global Aptamers Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Aptamers market was valued at 252 million in 2021 and is projected to reach US$ 811.5 million by 2028, at a CAGR of 18.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

DNA-Based Aptamers Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Aptamers include TriLink BioTechnologies, AptaBharat, SomaLogic, AM Biotechnologies, Aptamer Sciences, Base Pair Biotechnologies, Aptamer Group, Aptagen and Aptus Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Aptamers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Aptamers Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Aptamers Market Segment Percentages, by Type, 2021 (%)

• DNA-Based Aptamers
• RNA-Based Aptamers

Global Aptamers Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Aptamers Market Segment Percentages, by Application, 2021 (%)

• Research and Development
• Drug Discovery

Global Aptamers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Aptamers Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Aptamers revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Aptamers revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• TriLink BioTechnologies
• AptaBharat
• SomaLogic
• AM Biotechnologies
• Aptamer Sciences
• Base Pair Biotechnologies
• Aptamer Group
• Aptagen
• Aptus Biotech
• NeoVentures Biotechnology
• Ray Biotech
• Vivonics